Fmr LLC Cullinan Oncology, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Fmr LLC holds 679 shares of CGEM stock, worth $12,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares

679

Previous 526 29.09%

Holding current value

$12,181

Previous $8,000 37.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$15.63 - $29.35 $2,391 - $4,490	153 Added 29.09%	679 $11,000
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $854 - $1,597	84 Added 19.0%	526 $8,000
Q4 2023 Feb 13, 2024	SELL	$7.89 - $10.23 $8,931 - $11,580	-1,132 Reduced 71.92%	442 $4,000
Q3 2023 Nov 13, 2023	SELL	$9.05 - $11.72 $482,799 - $625,238	-53,348 Reduced 97.13%	1,574 $14,000
Q2 2023 Aug 11, 2023	BUY	$8.8 - $13.4 $5,720 - $8,710	650 Added 1.2%	54,922 $590,000
Q1 2023 May 11, 2023	SELL	$10.2 - $11.91 $347,962 - $406,297	-34,114 Reduced 38.6%	54,272 $555,000
Q4 2022 Feb 13, 2023	SELL	$9.72 - $13.62 $399,958 - $560,435	-41,148 Reduced 31.77%	88,386 $932,000
Q3 2022 Nov 10, 2022	SELL	$11.82 - $15.42 $999,168 - $1.3 Million	-84,532 Reduced 39.49%	129,534 $1.66 Million
Q2 2022 Aug 12, 2022	SELL	$7.31 - $13.55 $10.3 Million - $19.2 Million	-1,415,114 Reduced 86.86%	214,066 $2.74 Million
Q1 2022 May 13, 2022	BUY	$10.47 - $16.75 $7.22 Million - $11.5 Million	689,140 Added 73.31%	1,629,180 $17.1 Million
Q4 2021 Feb 14, 2022	SELL	$15.36 - $25.0 $24 Million - $39 Million	-1,560,172 Reduced 62.4%	940,040 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $11.8 Million - $15.5 Million	522,305 Added 26.41%	2,500,212 $56.4 Million
Q2 2021 Aug 13, 2021	BUY	$24.96 - $41.25 $49.4 Million - $81.6 Million	1,977,907 New	1,977,907 $50.9 Million

Others Institutions Holding CGEM

# of Institutions

140

Shares Held

65.9M

Call Options Held

77.2K

Put Options Held

15.9K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $818M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account